PharmacyCodes



Solifenacin succinate [USAN] en es it fr

Solifenacin succinate [USAN] Brand names, Solifenacin succinate [USAN] Analogs

Solifenacin succinate [USAN] Brand Names Mixture

  • No information avaliable

Solifenacin succinate [USAN] Chemical_Formula

C27H32N2O6

Solifenacin succinate [USAN] RX_link

http://www.rxlist.com/cgi/generic4/vesicare.htm

Solifenacin succinate [USAN] fda sheet

Solifenacin_succinate_[USAN] FDA

Solifenacin succinate [USAN] msds (material safety sheet)

Solifenacin succinate [USAN] Synthesis Reference

No information avaliable

Solifenacin succinate [USAN] Molecular Weight

480.553 g/mol

Solifenacin succinate [USAN] Melting Point

No information avaliable

Solifenacin succinate [USAN] H2O Solubility

No information avaliable

Solifenacin succinate [USAN] State

Solid

Solifenacin succinate [USAN] LogP

3.166

Solifenacin succinate [USAN] Dosage Forms

No information avaliable

Solifenacin succinate [USAN] Indication

For the treatment of micturition frequency/polyuria.

Solifenacin succinate [USAN] Pharmacology

Solifenacin succinate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Solifenacin succinate [USAN] Absorption

No information avaliable

Solifenacin succinate [USAN] side effects and Toxicity

No information avaliable

Solifenacin succinate [USAN] Patient Information

Solifenacin succinate [USAN] Organisms Affected

Humans and other mammals